News
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Kelly Evans Joins Cushman & Wakefield's Multi-Market Advisory Solutions Team as Senior Managing Director
Cushman & Wakefield (NYSE: CWK) has hired Kelly Evans as Senior Managing Director of the firm’s Multi-Market Advisory Solutions team, reporting to Paul Koenigsdorf, Executive Managing Director
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Cushman & Wakefield Recognized by USA TODAY as One of America’s Climate Leaders 2025
Cushman & Wakefield (NYSE: CWK), a leading global real estate services firm, was recognized on USA TODAY’s list of America’s Climate Leaders 2025. This award is presented by USA TODAY and Statista
LivaNova to Present at the Jefferies Global Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Cushman & Wakefield Hires Rich Okoney as Global Data Center Facilities Management Practice Lead
Rich Okoney has joined Cushman & Wakefield (NYSE: CWK) as Global Data Center Practice Lead in the firm’s Integrated Facility Management (IFM) Service Line team. Based in Connecticut, Okoney will
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Travis Perkins: Chief Executive Officer appointment
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Metro Bank Holdings PLC: First Quarter 2025 Trading Update
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2025 and updated full-year 2025 guidance.
Financial Summary
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced 12-month, top-line data from its OSPREY randomized controlled trial (RCT), evaluating outcomes with the